Health
Eli Lilly and FDA Allow Extraordinary Access to Obesity Drug
Eli Lilly and the FDA granted a 79-year-old patient extraordinary access to an experimental obesity drug through the agency’s compassionate use program.
Coverage timeline — 2 articles
STAT News
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.
2026-06-23 08:30 UTC
STAT News
EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart diseases.
2026-06-23 08:30 UTC